Food Enzymes

Enzymes used as processing aids or functional ingredients in food manufacturing, subject to safety assessment, production strain characterisation, and purity requirements.

Foresight tracks Food Enzymes developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.

Current activity

Intensifying

109% above the prior 8-week baseline

3-month trend

Latest alerts below

Last updated

9 April 2026, 17:36

Jump to alerts

Latest Food Enzymes alerts

The most recent regulatory and guidance signals tracked by Foresight

EFSA Evaluates Safety of Glucan 1,4‑α‑Glucosidase From GM Trichoderma reesei DP‑Nzh109

EFSA has confirmed the safety of glucan 1,4-α-glucosidase from GM Trichoderma reesei for starch and distilled alcohol production. This positive assessment paves the way for formal EU authorization, reducing compliance risk for food and beverage manufacturers utilizing this enzyme.

efsa.europa.euEuropean UnionEuropean Union

EU EFSA Panel Evaluates Extension Of Use For Food Enzyme Glucan 1,4‑α‑Maltohydrolase (NZYM‑SD)

EFSA has issued a positive safety opinion for extending the use of the food enzyme glucan 1,4-α-maltohydrolase to five food manufacturing processes, including plant-based milk analogues. This assessment clears a major technical hurdle for expanded market access and provides regulatory certainty for manufacturers using this enzyme in diverse food categories.

efsa.onlinelibrary.wiley.comEuropean UnionEuropean Union

EFSA Consults on Extension of Use of Alpha-Amylase Food Enzyme (GM Bacillus licheniformis NZYM-AV)

EFSA is consulting on the expanded use of alpha-amylase derived from genetically modified Bacillus licheniformis through April 2, 2026. Successful authorization would broaden market access for this specific enzyme, necessitating updates to food formulation compliance and labeling strategies.

open.efsa.europa.euEuropean UnionEuropean Union

EFSA Consults on Extension of Use for Food Enzyme Endo-1,4-β-Xylanase (Bacillus licheniformis NZYM-CE)

EFSA is consulting on extending the authorized uses for the food enzyme endo-1,4-β-xylanase (produced via GM strain) until April 3, 2026. Food and enzyme manufacturers should assess the proposed extensions to ensure alignment with product development and future EU market access requirements.

open.efsa.europa.euEuropean UnionEuropean Union

EFSA Adopts Opinion on Extension of Use of Cellulase Food Enzyme From GM Trichoderma reesei AR-852

EFSA published a positive safety opinion on March 26, 2026, supporting the extension of use and revised levels for the cellulase food enzyme from GM Trichoderma reesei. This assessment clears the path for the European Commission to formally authorize expanded applications in food and beverage processing, including cereals, brewing, and juices.

doi.orgEuropean UnionEuropean Union

EU EFSA Updates Safety Evaluation Of Cellulase Food Enzyme From GM Trichoderma reesei AR-852

EFSA has issued a positive safety opinion for the expanded use and revised concentration levels of cellulase from GM Trichoderma reesei in food manufacturing. This scientific endorsement facilitates the formal EU authorization process, potentially allowing broader application of the enzyme in food processing operations.

efsa.europa.euEuropean UnionEuropean Union

EU EFSA Registers Intake of Application to Modify Phospholipase C Food Enzyme (Bacillus licheniformis NZYM-VR)

EFSA has formally registered an application to modify the existing authorization for the food enzyme phospholipase C (produced by Bacillus licheniformis). This signals a forthcoming safety and technical review that may eventually alter market access conditions or usage specifications for food and beverage manufacturers using this enzyme.

open.efsa.europa.euEuropean UnionEuropean Union

EFSA Intake of Application for Alpha-Amylase Food Enzyme From GM Komagataella Phaffii

EFSA has initiated the safety assessment process for a new alpha-amylase food enzyme produced from a genetically modified strain of Komagataella phaffii. Manufacturers should monitor this dossier as its eventual approval will expand the list of authorized food enzymes and define specific purity and safety criteria for market access.

open.efsa.europa.euEuropean UnionEuropean Union

South Korea MFDS Consults On Draft Safety Review For GM Microorganism-Derived Cellulase Food Additive

South Korea's MFDS is consulting on a draft safety assessment for a GM microorganism-derived cellulase food additive through April 2026. This process signals a potential regulatory path for new biotech-derived ingredients, requiring manufacturers to ensure scientific data aligns with national food safety standards.

mfds.go.krSouth KoreaSouth Korea

EU EFSA Extends Clock Stop In Risk Assessment Of Cellulase And Hemicellulase Food Enzyme From Aspergillus luchuensis AE-C

EFSA has extended the risk assessment for cellulase and hemicellulase food enzymes from Aspergillus luchuensis, delaying the indicative completion date to April 2028. This extension prolongs regulatory uncertainty for the food industry, necessitating adjustments to innovation pipelines and market entry timelines for these specific enzyme preparations.

open.efsa.europa.euEuropean UnionEuropean Union

EFSA Ongoing Risk Assessment On Extension Of Use Of Bacillolysin Food Enzyme (Bacillus Amyloliquefaciens HPN 131)

EFSA is evaluating an application to extend the authorized uses of the food enzyme bacillolysin, with a final scientific opinion due by September 2026. Successful assessment will likely lead to expanded market access and updated compliance requirements for food processors using this enzyme in the EU.

open.efsa.europa.euEuropean UnionEuropean Union

EU EFSA Registers Follow-Up Alpha-Amylase Food Enzyme Application (EFSA-Q-2026-00173)

EFSA has commenced the safety assessment for a follow-up application to authorize alpha-amylase derived from a genetically modified strain. This evaluation is a mandatory precursor to market access, requiring food producers to monitor the outcome for future formulation and compliance planning.

open.efsa.europa.euEuropean UnionEuropean Union

EFSA Ongoing Risk Assessment of Extension of Use of Alpha-Amylase Food Enzyme (Bacillus licheniformis NZYM-AN)

EFSA is reviewing an application to extend the authorized uses of the alpha-amylase food enzyme, with a scientific opinion expected by November 2026. Success will broaden formulation flexibility for food producers, while the assessment process signals continued scrutiny of enzymes derived from genetically modified organisms.

open.efsa.europa.euEuropean UnionEuropean Union

EFSA Launches Public Consultation on Glutaminase Food Enzyme From GM Bacillus subtilis Glu3-3

EFSA is consulting on the safety of glutaminase from genetically modified Bacillus subtilis, with a final risk assessment expected by June 2026. This assessment is a critical step for the legal authorization of this enzyme, impacting future formulation options and supply chain compliance for food processors.

open.efsa.europa.euEuropean UnionEuropean Union

EU EFSA Receives Application to Authorise Transglutaminase Food Enzyme

EFSA has initiated the suitability check for the authorization of transglutaminase as a food enzyme for inclusion in the EU Union list. This marks the start of a formal risk assessment process that will determine future market access and permissible conditions of use for food manufacturers.

open.efsa.europa.euEuropean UnionEuropean Union

EU EFSA Registers Intake of Application to Modify Food Enzyme NZYM-ST (Beta-Glucanase, Xylanase, Cellulase)

EFSA has initiated the assessment of an application to modify the authorization for the food enzyme preparation NZYM-ST (beta-glucanase, xylanase, and cellulase). This development signals potential updates to EU market authorization conditions, requiring manufacturers to track the assessment for future compliance adjustments.

open.efsa.europa.euEuropean UnionEuropean Union

China CFSA Consults on Four New Food Additives Including Two HMOs

China is moving to authorize four new food additives and nutrition enhancers, including HMOs for infant formula, following successful technical safety reviews by the CFSA. This signals imminent updates to national food safety standards, expanding market access for specialized ingredients in the infant nutrition and food processing sectors.

cfsa.net.cnChinaChina

EFSA Opens Consultation On Authorisation of Phospholipase A1 Food Enzyme From Genetically Modified Komagataella phaffii (Strain PHLSC)

EFSA has launched a public consultation on the authorization of a new phospholipase A1 food enzyme derived from genetically modified sources, with comments due by March 24, 2026. This regulatory milestone is a prerequisite for EU market entry, requiring food processors and biotech firms to monitor the assessment outcome for future product development and compliance.

open.efsa.europa.euEuropean UnionEuropean Union

EU (EFSA) Public Consultation on Authorisation of Phospholipase A1 From Fusarium commune Strain LFC as a New Food Enzyme

EFSA has launched a public consultation on the authorization of Phospholipase A1 as a new food enzyme, with a risk assessment deadline set for October 2026. Food processors should monitor this assessment as it will determine the future market access and approved use conditions for this enzyme in the EU.

open.efsa.europa.euEuropean UnionEuropean Union

EFSA Opens Consultation on Extension of Use for Alpha-Amylase Food Enzyme (Aspergillus niger NZYM-SB)

EFSA is reviewing an application to expand the permitted food processing uses for alpha-amylase enzymes derived from genetically modified Aspergillus niger. Approval would provide food manufacturers with broader operational flexibility and updated compliance parameters for enzyme-assisted production processes.

open.efsa.europa.euEuropean UnionEuropean Union

Not a newsletter. Not a feed. Structured intelligence mapped to your business.

These are just a few of the most recent Food Enzymes alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.

Book a demo

Frequently asked questions

Everything you need to know about Foresight's regulatory intelligence platform

Still have questions? Get in touch with our team

Join 3,500+ professionals staying ahead

Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.

Free forever. Unsubscribe anytime.

Read by professionals at

Boeing
AstraZeneca
Siemens
PepsiCo
SpaceX